$HQL insiders have traded $HQL stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales. Here’s a ...
HQL is a closed-end fund focused on investments in the life sciences industry, especially risky biotechnology stocks that make up 74% of its portfolio. This leads to a 'boom-bust' returns profile that ...
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 / abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, ...
abrdn Life Sciences Investors Fund maintains a buy rating, offering a compelling 11.6% yield and trading at a 9.58% NAV discount. HQL’s income-focused strategy relies on net realized gains, supporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results